promising anti-cancer drug
standard drug delivery mechanisms
leading drug delivery platform organisation
cancer treatment
solid business
new nano-tech drug development specialism
initial cancer cell therapy control drug
nano-fibres
biodegradable nano-gauze
biomedical nano-fibre
experts
SN
low solubility
solid employment growth
medical business entrepreneurs
single minded vision
paediatric solid tumours Cebiotex
treatment area
proprietary gauze
product line
surgical therapy of adult
world leading hospital
depositing of active agents
European medical biotech sector
targeted SME Instrument funding
company
Sant Joan
researchers
order
unique method
DÃ©u
drugs
adoption
constant high dosage
cells
oncology sectors
place
plans
focus
advantage
predictions
Nanofiber
Universitat Politecnica
treatments
Catalunya
patented process
technology
years
commercial groundwork
multiple fields
weeks
trials
problem
assumptions
spearhead